NAMENDA Side Effects

6602612-3 | Angioedema
on Feb 03, 2010 Female patient from UNITED STATES , 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral, 10 Mg (5 Mg, 2 In 1 D), Oral. Patient was hospitalized.

6599956-0 | Fall, Hypersomnia, Incontinence, Myoclonus, Subdural Haemorrhage, Urinary Retention
Patient was taking Namenda (View Usage). Patient had the following side effects: fall (What is fall?), hypersomnia, incontinence, myoclonus, subdural haemorrhage, urinary retention on Feb 10, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg( 5 Mg, 2 In 1 D), Oral; 15 Mg D, Oral. During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ). Patient was hospitalized.

6599948-1 | Abdominal Pain, Arthritis, Cholecystitis, Endometrial Disorder, Mass
Adverse event was reported on Feb 12, 2010 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral, 10 Mg (5 Mg, 2 In 1 D), Oral, 15 Mg (2 In 1 D), Oral, 20 Mg (10 Mg, 2 I) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 77 years of age, After Namenda was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), arthritis (What is arthritis?), cholecystitis, endometrial disorder, mass. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PROZAC (View Prozac Review and Prozac Label ), ULTRAM (View Ultram Review and Ultram Label ), ALTACE (View Altace Review and Altace Label ).

6598638-9 | Abasia, Communication Disorder, Decreased Appetite, Drooling, Dysphagia, Dysstasia, Feeding Disorder, Hearing Impaired, Loss Of Consciousness
on Feb 19, 2010 Female patient from UNITED STATES , 89 years of age, weighting 147.3 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, communication disorder, decreased appetite, drooling, dysphagia, dysstasia, feeding disorder, hearing impaired, loss of consciousness. Namenda dosage: Namenda 2 Pills At Night. During the same period patient was treated with EXELON (Exelon Patch Daily) (View Exelon Review and Exelon Label ). Patient was hospitalized.


6582632-8 | Abdominal Pain, Arthritis, Gallbladder Disorder, Glaucoma, Uterine Mass
on Jan 25, 2010 Female patient from UNITED STATES , 77 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthritis (What is arthritis?), gallbladder disorder, glaucoma (What is glaucoma?), uterine mass. Namenda dosage: See Image. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), SIMVASTATIN (40 MILLIGRAM, TABLETS) (View Simvastatin (40 Milligram, Tablets) Review and Simvastatin (40 Milligram, Tablets) Label ), PROZAC (20 MILLIGRAM, TABLETS) (View Prozac (20 Milligram, Tablets) Review and Prozac (20 Milligram, Tablets) Label ), ULTRAM ER (200 MILLIGRAM, TABLETS) (View Ultram Er (200 Milligram, Tablets) Review and Ultram Er (200 Milligram, Tablets) Label ), ALTACE (5 MILLIGRAM, TABLETS) (View Altace (5 Milligram, Tablets) Review and Altace (5 Milligram, Tablets) Label ).

6575794-X | Abasia, Activities Of Daily Living Impaired, Balance Disorder, Convulsion, Eating Disorder, Fall, Hypersomnia, Hypokinesia, Mastication Disorder
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: abasia, activities of daily living impaired, balance disorder, convulsion, eating disorder (What is eating disorder?), fall (What is fall?), hypersomnia, hypokinesia, mastication disorder on Feb 08, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, weighting 110.0 lb, was diagnosed with dementia alzheimer's type and. Namenda dosage: 1 Tab Twice A Day Po.

6538539-5 | Confusional State, Disorientation
Adverse event was reported on Jan 13, 2010 by a Female patient taking Namenda (View Usage) (Dosage: Namenda Starter Pack (5mg +10mg) 1 5 Mg Wk#1 2 5mg Wk#2 1 10mg + 1 5mg Wk#3 2 10mg Daily Wk#4) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 66 years of age, weighting 190.5 lb, Patient experienced the following unwanted or unexpected effects: confusional state, disorientation. During the same period patient was treated with EXELON (View Exelon Review and Exelon Label ).

6389484-X | Bradycardia, Face Injury, Fall, Loss Of Consciousness, Syncope
on Sep 29, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: bradycardia, face injury, fall (What is fall?), loss of consciousness, syncope. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D),oral; 10 Mg (5 Mg,2 In 1 D),oral; 15 Mg,oral; 20 Mg (10 Mq, 2 In 1 D),oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), CELEXA (View Celexa Review and Celexa Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

6381097-9 | Erythema, Oedema Peripheral
on Sep 25, 2009 Male patient from UNITED STATES , 72 years of age, weighting 202.0 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: erythema, oedema peripheral. Namenda dosage: 10 Mg Was Changed To 5 Mg Morning + Night Po.

6375114-X | Abnormal Behaviour, Delirium, Paranoia
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, delirium, paranoia on Sep 17, 2009 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 106.0 lb, was diagnosed with dementia alzheimer's type and. Namenda dosage: 5mg Qhs Po. Patient was hospitalized.

6368691-6 | Delusion, Paranoia, Psychotic Disorder
Adverse event was reported on Sep 17, 2009 by a Female patient taking Namenda (View Usage) (Dosage: 5mg Once Daily Po) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , 74 years of age, weighting 136.0 lb, Patient had the following side effects: delusion, paranoia, psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

6347303-1 | Convulsion, Dystonia, Muscle Spasms, Myalgia, Tension
on Sep 08, 2009 Female patient from UNITED STATES , 14 years of age, weighting 157.0 lb, was diagnosed with tourette's disorder and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: convulsion, dystonia (What is dystonia?), muscle spasms, myalgia, tension. Namenda dosage: 5mg Once Every Morning Po.

6337324-7 | Depression, Dysphoria, Suicidal Ideation, Tearfulness
on Aug 28, 2009 Female patient from UNITED STATES , 89 years of age, weighting 124.0 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dysphoria, suicidal ideation, tearfulness. Namenda dosage: 5 Mg 2x/day Po.

6322324-3 | Dizziness, Hallucination, Muscular Weakness, Screaming, Tremor
Patient was taking Namenda (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hallucination, muscular weakness, screaming, tremor on Aug 17, 2009 from UNITED STATES Additional patient health information: Female patient , 97 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT (10 Mg (10 Mg, 1 In 1 D), Oral) (View Aricept Review and Aricept Label ), ALLEGRA (5 MILLIGRAM, TABLETS) (5 Mg) (View Allegra (5 Milligram, Tablets) Review and Allegra (5 Milligram, Tablets) Label ), EXELON (View Exelon Review and Exelon Label ). Patient was hospitalized.

6312642-7 | Completed Suicide
Adverse event was reported on Aug 10, 2009 by a Male patient taking Namenda (View Usage) (Dosage: ) . Location: UNITED STATES , 78 years of age, After Namenda was administered, patient had the following side effects: completed suicide. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

6268028-7 | Gastrointestinal Haemorrhage, Hiatus Hernia, Peptic Ulcer
on Jul 10, 2009 Female patient from UNITED STATES , 82 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, hiatus hernia, peptic ulcer (What is peptic ulcer?). Namenda dosage: 5 Mg (5mg, 1 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), REMERON (View Remeron Review and Remeron Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), AMBIEN (View Ambien Review and Ambien Label ), MEGACE (View Megace Review and Megace Label ). Patient was hospitalized.

6259366-2 | Erythema, Rash, Renal Failure Chronic
on Jun 29, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: erythema, rash (What is rash?), renal failure chronic. Namenda dosage: See Image. During the same period patient was treated with THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ).

6240825-3 | Condition Aggravated, Dementia
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: condition aggravated, dementia (What is dementia?) on Jun 15, 2009 from UNITED STATES Additional patient health information: Female patient , 97 years of age, was diagnosed with dementia (What is dementia?) and. Namenda dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

6215395-6 | Anaemia, Cardiac Arrest, Clostridial Infection, Decubitus Ulcer, Dysphagia, Movement Disorder, Myocardial Infarction
Adverse event was reported on May 29, 2009 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral, 10 Mg (5 Mg, 2 In 1 D), Oral, (2 In 1 D), 20 Mg (10 Mg, 2 In 1 D), Oral) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, cardiac arrest (What is cardiac arrest?), clostridial infection, decubitus ulcer, dysphagia, movement disorder (What is movement disorder?), myocardial infarction. During the same period patient was treated with AMANTADINE HCL (20 Mg (10 Mg, 2 In 1 D)) (View Amantadine Hcl Review and Amantadine Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ). Patient was hospitalized.

6213838-5 | Catatonia, Condition Aggravated, Confusional State, Dementia, Fluid Intake Reduced, Hypophagia, Paranoia
on Jun 01, 2009 Female patient from UNITED STATES , 78 years of age, weighting 190.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: catatonia, condition aggravated, confusional state, dementia (What is dementia?), fluid intake reduced, hypophagia, paranoia. Namenda dosage: 10 Mg Daily Po. Patient was hospitalized.

6202560-7 | Decreased Appetite, Dry Skin, Inflammation, Pruritus, Rash Papular, Renal Failure Chronic, Skin Discolouration, Skin Exfoliation, Weight Decreased
on May 21, 2009 Male patient from UNITED STATES , 73 years of age, weighting 145.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: decreased appetite, dry skin, inflammation, pruritus, rash papular, renal failure chronic, skin discolouration, skin exfoliation, weight decreased. Namenda dosage: 10 Mg. Bid Po.

6198047-0 | Gastrointestinal Haemorrhage, Hiatus Hernia, Peptic Ulcer
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, hiatus hernia, peptic ulcer (What is peptic ulcer?) on May 11, 2009 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), REMERON (View Remeron Review and Remeron Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), AMBIEN (View Ambien Review and Ambien Label ), MEGACE (View Megace Review and Megace Label ). Patient was hospitalized.

6192574-8 | Chest Pain, Disorientation, Dizziness, Dyspnoea, Palpitations, Tremor
Adverse event was reported on May 14, 2009 by a Male patient taking Namenda (View Usage) (Dosage: 5mg X 7 Days Daily Oral Up To 15 Mg/day Before D/c) was diagnosed with dementia (What is dementia?) and. Location: UNITED STATES , weighting 196.0 lb, Patient had the following side effects: chest pain (What is chest pain?), disorientation, dizziness (What is dizziness?), dyspnoea, palpitations, tremor. Patient was hospitalized.

6188705-6 | Cerebral Haemorrhage, Cerebrovascular Accident, Condition Aggravated, Fall, Heart Valve Incompetence, Intracardiac Thrombus, Memory Impairment, Screaming
on May 11, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: cerebral haemorrhage, cerebrovascular accident, condition aggravated, fall (What is fall?), heart valve incompetence, intracardiac thrombus, memory impairment, screaming. Namenda dosage: . During the same period patient was treated with NITRO DURA (View Nitro Dura Review and Nitro Dura Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), ACTONEL (View Actonel Review and Actonel Label ), CORAL CALUIM (View Coral Caluim Review and Coral Caluim Label ), ATACAND (View Atacand Review and Atacand Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CELEBREX (View Celebrex Review and Celebrex Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ).

6187780-2 | Belligerence, Coprolalia, Homicidal Ideation, Screaming
on May 11, 2009 Female patient from UNITED STATES , 56 years of age, weighting 160.0 lb, was diagnosed with fall (What is fall?), hepatitis c (What is hepatitis c?), hiv infection (What is hiv infection?), memory impairment and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: belligerence, coprolalia, homicidal ideation, screaming. Namenda dosage: 10 Mg 1st Week 2 Next Oral.

6185908-1 | Influenza
Patient was taking Namenda (View Usage). Patient had the following side effects: influenza on May 01, 2009 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with dementia (What is dementia?), dementia alzheimer's type and. Namenda dosage: . Patient was hospitalized.

6185832-4 | Anaemia, Cardiac Arrest, Clostridial Infection, Condition Aggravated, Decubitus Ulcer, Dysphagia, Movement Disorder
Adverse event was reported on May 04, 2009 by a Female patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg ( 5 Mg, 2 In 1 D), Oral; 2 In 1 D; 20 Mg (10 Mg, 2 In 1 D), Oral) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 84 years of age, After Namenda was administered, patient had the following side effects: anaemia, cardiac arrest (What is cardiac arrest?), clostridial infection, condition aggravated, decubitus ulcer, dysphagia, movement disorder (What is movement disorder?). During the same period patient was treated with AMANTADINE HCL (20 Mg (10 Mg, 2 In 1 D)) (View Amantadine Hcl Review and Amantadine Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

6179236-8 | Blood Prolactin Increased, Convulsion
on Apr 28, 2009 Male patient from UNITED STATES , 70 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: blood prolactin increased, convulsion. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOCUSATE (View Docusate Review and Docusate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SENOKOT (View Senokot Review and Senokot Label ).

6152505-3 | Anaemia, Aphasia, Clostridial Infection, Condition Aggravated, Decubitus Ulcer, Drooling, Dysphagia
on Apr 02, 2009 Female patient from UNITED STATES , 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient had the following side effects: anaemia, aphasia (What is aphasia?), clostridial infection, condition aggravated, decubitus ulcer, drooling, dysphagia. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with AMANTADINE HCL (20 Mg (10 Mg, 2 In 3 D)) (View Amantadine Hcl Review and Amantadine Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6147135-3 | Anaemia, Asthenia, Atelectasis, Bone Marrow Failure, Cerebral Haemorrhage, Disorientation, Hepatic Lesion, Leukopenia, Megakaryocytes Decreased
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: anaemia, asthenia, atelectasis, bone marrow failure, cerebral haemorrhage, disorientation, hepatic lesion, leukopenia, megakaryocytes decreased on Mar 23, 2009 from UNITED STATES Additional patient health information: Female patient , 87 years of age, weighting 135.0 lb, was diagnosed with dementia (What is dementia?) and. Namenda dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized.

6138049-3 | Dementia, Hypersomnia, Hypophagia
Adverse event was reported on Mar 27, 2009 by a Female patient taking Namenda (View Usage) (Dosage: Bid 10 Am) . Location: UNITED STATES , 72 years of age, weighting 131.0 lb, Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), hypersomnia, hypophagia.

6137454-9 | Alanine Aminotransferase Increased, Ammonia Increased, Aspartate Aminotransferase Increased, Asthenia, Biliary Dilatation, Blood Alkaline Phosphatase Increased, Chest Pain, Confusional State, Heart Rate Increased
on Mar 20, 2009 Male patient from UNITED STATES , 86 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, asthenia, biliary dilatation, blood alkaline phosphatase increased, chest pain (What is chest pain?), confusional state, heart rate increased. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral; 10 Mg (5 Mg, 2 In 1 D), Oral; 15 Mg, Oral. During the same period patient was treated with GLEEVEC (TABLETS) (View Gleevec (tablets) Review and Gleevec (tablets) Label ), AVANDIA (TABLETS) (View Avandia (tablets) Review and Avandia (tablets) Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VASOTEC (View Vasotec Review and Vasotec Label ). Patient was hospitalized.

6129790-7 | Hallucinations, Mixed
on Mar 23, 2009 Female patient from UNITED STATES , weighting 117.0 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: hallucinations, mixed. Namenda dosage: 10 Mg Bid Po.

6093395-7 | Aggression, Alcohol Interaction, Alcohol Use, Irritability, Overdose, Pneumonia Aspiration
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, alcohol interaction, alcohol use, irritability, overdose, pneumonia aspiration on Feb 23, 2009 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 155.0 lb, was diagnosed with dementia (What is dementia?), prophylaxis and. Namenda dosage: 10mg Bid Po About 2-3 Weeks. Patient was hospitalized.

6074791-0 | Abasia, Aphasia, Convulsion, Cystitis, Lower Limb Fracture, Refusal Of Treatment By Relative
Adverse event was reported on Jan 30, 2009 by a Male patient taking Namenda (View Usage) (Dosage: 20 Mg (10 Mg, 2 Kin 1 D), Oral, 10 Mg (5 Mg, 2 In 1 D), Oral) was diagnosed with dementia alzheimer's type, cystitis and. Location: UNITED STATES , 81 years of age, Patient had the following side effects: abasia, aphasia (What is aphasia?), convulsion, cystitis, lower limb fracture, refusal of treatment by relative. During the same period patient was treated with CIPRO (1000 (500 Mg, 2 In 1 D), Oral) (View Cipro Review and Cipro Label ), ATIVAN (View Ativan Review and Ativan Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VICODIN (View Vicodin Review and Vicodin Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6073005-5 | Anaemia, Cerebral Haemorrhage, Leukopenia, No Therapeutic Response, Thrombocytopenia
on Feb 09, 2009 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: anaemia, cerebral haemorrhage, leukopenia, no therapeutic response, thrombocytopenia. Namenda dosage: 5-10 Mg Bid Po. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized and became disabled.

6038926-8 | Gastrointestinal Haemorrhage, Haemorrhagic Anaemia
on Jan 14, 2009 Female patient from UNITED STATES , 64 years of age, weighting 84.00 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, haemorrhagic anaemia. Namenda dosage: 1 Tablet Twice Daily Po. Patient was hospitalized.

6036422-5 | Torsade De Pointes
Patient was taking Namenda (View Usage). Patient had the following side effects: torsade de pointes on Jan 06, 2009 from UNITED STATES Additional patient health information: Female patient , 71 years of age, . Namenda dosage: . During the same period patient was treated with COREG (View Coreg Review and Coreg Label ), CALCIUM (View Calcium Review and Calcium Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ARICEPT (View Aricept Review and Aricept Label ).

5998015-5 | Aggression, Agitation, Communication Disorder, Convulsion, Disease Recurrence, Loss Of Consciousness, Postictal State, Tremor
Adverse event was reported on Dec 05, 2008 by a Male patient taking Namenda (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D),oral) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 70 years of age, After Namenda was administered, patient had the following side effects: aggression, agitation, communication disorder, convulsion, disease recurrence, loss of consciousness, postictal state, tremor. During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOCUSATE (View Docusate Review and Docusate Label ).

5978481-1 | Pancreatitis
on Nov 19, 2008 Female patient from UNITED STATES , 75 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D),oral; 10 Mg (5mg, 2 In 1 D),oral; 15 Mg,oral; 20 Mg (10mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), BONIVA (View Boniva Review and Boniva Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), GLUCOSAMINE CHONDROITIN (View Glucosamine Chondroitin Review and Glucosamine Chondroitin Label ).

5977182-3 | Mental Status Changes, Road Traffic Accident
on Nov 20, 2008 Male patient from UNITED STATES , 80 years of age, was diagnosed with dementia (What is dementia?) and was treated with Namenda (View Usage). Patient had the following side effects: mental status changes, road traffic accident. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FLOMAX (View Flomax Review and Flomax Label ), DETROL LA (View Detrol La Review and Detrol La Label ), CLARINEX (View Clarinex Review and Clarinex Label ), PACERONE (View Pacerone Review and Pacerone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PLAVIX (View Plavix Review and Plavix Label ).

5939535-9 | Blood Glucose Increased, Decubitus Ulcer, Fall, Incorrect Dose Administered, Nosocomial Infection, Overdose, Pneumonia, Staphylococcal Infection
Patient was taking Namenda (View Usage). After Namenda was administered, patient had the following side effects: blood glucose increased, decubitus ulcer, fall (What is fall?), incorrect dose administered, nosocomial infection, overdose, pneumonia (What is pneumonia?), staphylococcal infection (What is staphylococcal infection?) on Oct 23, 2008 from UNITED STATES Additional patient health information: Male patient , 77 years of age, was diagnosed with dementia alzheimer's type and. Namenda dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ). Patient was hospitalized.

5929245-6 | Asthenia, Dizziness, Dyspnoea, Hallucination, Visual, Movement Disorder
Adverse event was reported on Oct 23, 2008 by a Male patient taking Namenda (View Usage) (Dosage: 5mg Bid Po) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 84 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), dyspnoea, hallucination, visual, movement disorder (What is movement disorder?). Patient was hospitalized.

5920110-7 | Confusional State, Hypophagia, Mental Status Changes, Oral Candidiasis, Pneumonia
on Oct 15, 2008 Female patient from UNITED STATES , weighting 129.0 lb, was treated with Namenda (View Usage). Patient had the following side effects: confusional state, hypophagia, mental status changes, oral candidiasis, pneumonia (What is pneumonia?). Namenda dosage: 330 Mg. During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ).

5870090-8 | Agitation, Back Pain, Blood Pressure Increased, Cerebral Atrophy, Encephalopathy, Hallucination, Hypophagia, Mobility Decreased, Normal Pressure Hydrocephalus
on Aug 14, 2008 Male patient from UNITED STATES , 70 years of age, weighting 209.0 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: agitation, back pain (What is back pain?), blood pressure increased, cerebral atrophy, encephalopathy, hallucination, hypophagia, mobility decreased, normal pressure hydrocephalus. Namenda dosage: 5 Mg (5 Mg, 1 In 1 D), Oral, 10 Mg (5 Mg, 2 In 1 D), Oral, 15mg (15 Mg), 20 Mg (10 Mg, 2 In 1 D), Or. During the same period patient was treated with AGGRENOX (View Aggrenox Review and Aggrenox Label ), LIPITOR (20 MILLIGRAM, TABLETS) (View Lipitor (20 Milligram, Tablets) Review and Lipitor (20 Milligram, Tablets) Label ), ARICEPT (View Aricept Review and Aricept Label ), AVODART (0.5 MILLIGRAM, CAPSULES) (View Avodart (0.5 Milligram, Capsules) Review and Avodart (0.5 Milligram, Capsules) Label ), GLIPIZIDE (5 MILLIGRAM, TABLETS) (View Glipizide (5 Milligram, Tablets) Review and Glipizide (5 Milligram, Tablets) Label ). Patient was hospitalized.

5816515-5 | Aggression, Anxiety
Patient was taking Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anxiety (What is anxiety?) on Jul 17, 2008 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 145.0 lb, was diagnosed with confusional state and. Namenda dosage: 5 Mg Once Per Day. Patient was hospitalized.

5813345-5 | Aerophagia, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Sodium Decreased, Bundle Branch Block Left, Dysphagia, Eructation, Exostosis, Fall
Adverse event was reported on Jun 30, 2008 by a Female patient taking Namenda (View Usage) (Dosage: 10 Mg Bid Po) was diagnosed with dementia alzheimer's type and. Location: UNITED STATES , 80 years of age, weighting 160.9 lb, Patient had the following side effects: aerophagia, aspartate aminotransferase increased, blood creatinine increased, blood sodium decreased, bundle branch block left, dysphagia, eructation, exostosis, fall (What is fall?). During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), KLOR CON (POTASSIUM) (View Klor-con (potassium) Review and Klor-con (potassium) Label ), ARICEPT (View Aricept Review and Aricept Label ), NEXIUM (View Nexium Review and Nexium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), TYLENOL PM (ACETAMINOPHEN AND DIPHENHYDRAMINE) (View Tylenol Pm (acetaminophen And Diphenhydramine) Review and Tylenol Pm (acetaminophen And Diphenhydramine) Label ). Patient was hospitalized.

5813335-2 | Aspartate Aminotransferase Increased, Blood Creatinine Increased, Blood Sodium Decreased, Bundle Branch Block Left, Dysphagia, Eructation, Exostosis, Fall, Haemoglobin Decreased
on Jun 30, 2008 Female patient from UNITED STATES , 80 years of age, weighting 160.9 lb, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). After Namenda was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatinine increased, blood sodium decreased, bundle branch block left, dysphagia, eructation, exostosis, fall (What is fall?), haemoglobin decreased. Namenda dosage: 5 Ml Bid Po. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), KLOR CON (POTASSIUM) (View Klor-con (potassium) Review and Klor-con (potassium) Label ), ARICEPT (View Aricept Review and Aricept Label ), NEXIUM (View Nexium Review and Nexium Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM (View Calcium Review and Calcium Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), TYLENOL PM (ACETAMINOPHEN AND DIPHENHYDRAMINE) (View Tylenol Pm (acetaminophen And Diphenhydramine) Review and Tylenol Pm (acetaminophen And Diphenhydramine) Label ). Patient was hospitalized.

5805291-8 | Dehydration, Oedema Peripheral, Pyrexia, Renal Failure
on Jun 24, 2008 Female patient from UNITED STATES , 85 years of age, was diagnosed with dementia alzheimer's type and was treated with Namenda (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, oedema peripheral, pyrexia, renal failure. Namenda dosage: 10 Mg Bid Po. Patient was hospitalized.

5788209-6 | Aggression, Anger, Chronic Obstructive Pulmonary Disease, Disease Recurrence, Paranoia, Pneumonia, Respiratory Arrest
Patient was taking Namenda (View Usage). Patient had the following side effects: aggression, anger, chronic obstructive pulmonary disease, disease recurrence, paranoia, pneumonia (What is pneumonia?), respiratory arrest on Jun 13, 2008 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with schizophrenia, paranoid type and. Namenda dosage: 10 Mg Qd Po. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), ABILIFY (View Abilify Review and Abilify Label ), SERAX (View Serax Review and Serax Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), CRESTOR (View Crestor Review and Crestor Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).